HENGRUI PHARMA

01276
42.9205.25% ( -2.380 )
Delay Closed: Nov 20, 16:08:00

Valuation

Current ValuationThe current P/E ratio is 27.53, below the reasonable range, cheaper than 99.62% of the time in the past 1 years, and the industry ranks 28/54, the industry Median 7.34.

27.53xP/E
Stock priceHK$42.92Earnings per shareHK$1.56

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 7.34x
09182736

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 7.34x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
01276HKHENGRUI PHARMA
27.53x22.18%HK$284.87B
03692HKHANSOH PHARMA
24.24x23.06%HK$186.41B
06821HKAsymchem
27.20x27.07%HK$37.53B
03933HKUNITED LAB
21.85x55.30%HK$13.57B
09989HKHEPALINK
25.15x18.84%HK$5.56B
06996HKANTENGENE-B
27.22x246.19%HK$1.68B
03737HKZHONGZHIPHARM
26.60x--HK$539.75M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.